Novadip Biosciences

Bone Reconstruction and Orthopaedic Repair

Clinical research centres on bone regeneration, osteogenic implants, and surgical restoration of structural integrity in complex fractures and nonunion conditions. The sponsor’s trials include adult and paediatric settings with attention to recalcitrant lower limb nonunion and distal radius fractures.

  • Autologous bone graft approaches
  • Osteogenic implant development
  • Fracture healing and nonunion repair

Research activity also covers local and systemic safety considerations associated with reconstructive orthopaedic procedures and implanted regenerative materials.

Paediatric Orthopaedics in Congenital Pseudarthrosis of the Tibia

The sponsor funds studies focused on congenital pseudarthrosis of the tibia, with a strong emphasis on paediatric surgical treatment and the functional restoration of tibial continuity. This area reflects interest in challenging childhood bone disorders requiring specialised reconstructive care.

  • Paediatric bone reconstruction
  • Tibial pseudarthrosis
  • Congenital skeletal disorders

Trials in this domain examine both treatment effectiveness and the safety profile of regenerative orthopaedic interventions in younger patients.

Spine Fusion and Degenerative Lumbar Disease

Another therapeutic focus is low grade degenerative lumbar spondylolisthesis, studied in the context of interbody spine fusion. The sponsor’s work in this field addresses structural spinal stability and bone integration in adult patients with degenerative lumbar conditions.

  • Degenerative spine disorders
  • Lumbar spondylolisthesis
  • Interbody fusion

Research in this area is linked to implanted osteogenic materials intended to support spinal reconstruction and fusion outcomes.

Implant Safety and Long-term Clinical Tolerability

Across its portfolio, the sponsor places substantial emphasis on clinical safety, radiological safety, and longer-term tolerability of allogenic and autologous implant-based therapies. This includes monitoring of surgical and tissue-collection procedures associated with regenerative bone treatment.

  • Long-term implant safety
  • Clinical and radiological monitoring
  • Autologous and allogenic origin implants

The research portfolio spans multiple active sites and countries, reflecting ongoing interest in orthopaedic regenerative medicine.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of NVD003 stem cell implant compared to bone graft for children with congenital pseudarthrosis of the tibia

    Recruiting

    1 1 1
    Investigated diseases:
    Belgium France Spain
  • Study on the Safety and Effectiveness of NVD-003 Implant for Adults with Difficult-to-Heal Lower Leg Bone Fractures

    Recruiting

    1 1
    Belgium Luxembourg
  • Study on Long-term Safety of NVDX3 Implant for Patients with Distal Radius Fracture or Low-grade Degenerative Lumbar Spondylolisthesis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Luxembourg
  • Study on NVD-003 Bone Graft for Treating Congenital Pseudarthrosis of the Tibia in Children

    Not recruiting

    1 1
    Investigated diseases:
    Belgium